Kosher Pharmaceuticals

Our team of qualified chemical engineers and pharmacists effectively formulate cardiovascular tablets, atorvastatin tablets (10mg). These bear accurate composition and are film coated for protection against temperature and humidity. Following are the highlighting features of atorvastatin tablets :

• Completely synthetic compound
  
• HMG-CoA reductase catalyzes the reduction of 3-hydroxy-3-methylglutaryl-coenzyme Inhibition of the enzyme decreases de novo cholesterol synthesis
• Increases expression of low-density lipoprotein receptors (LDL receptors) on hepatocytes
• Competitive inhibitor of HMG-CoA reductase
• Reduces blood levels of triglycerides and slightly increases levels of HDL-cholesterol
• Increases LDL uptake by the hepatocytes
• Decreases the amount of LDL-cholesterol in the blood

Specifications :

• Color: White
  
• Shape: Elliptical
• Finish: Film coated Atorvastatin is a completely synthetic compound.

It is not recommended in case of :

• active liver disease: cholestasis, hepatic encephalopathy, hepatitis and jaundice.
• Unexplained elevations in AST or ALT levels
• Pregnancy
• Breast-feeding

The clopidogrel tablets manufactured by us are in high demand in hospitals and health centers worldwide. Available in 75mg concentrations, these cardiovascular drugs or cardiac drug tablets contains clopidogrel bisulfate and a lubricant selected from zinc stearate, stearic acid and sodium stearyl fumarate. Our tablets are safe to consume and are offered in tamper proof packaging.

We manufacture cardiovascular medications, cardiovascular tablets with diltiazem that have accurate composition and are available in 30mg, 60mg concentration. These diltiazem tablets are formulated by using high grade chemicals and are recommended by doctors worldwide for the following disorders :

• sick sinus syndrome .
  
• atrio ventricular node conduction disturbances.
  
• bradycardia.
• impaired left ventricle function .
  
• peripheral artery occlusive disease.
• chronic obstructive pulmonary disease .
  
• prinzmetal's angina.

Our dopamine hydrochloride injection is an cardoiz medicine additive solution for intravenous infusion after dilution. Being a potent drug, these need to be diluted before administration to patient. These cardiac drugs are clear, practically colorless, aqueous, and offered in 200mg or in 5ml quantities. Following are the essential characteristics of dopamine :

• Natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA)
  
• Precursor to norepinephrine in noradrenergic nerves
• Neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract and peripheral sympathetic nerves
  
• Produces positive chronotropic and inotropic effects on the myocardium,
• Increases heart rate and cardiac contractility
  
• Accomplished directly by exerting an agonist action on beta-adrenoceptors
  
• Causes release of norepinephrine from storage sites in sympathetic nerve endings

The ramipril tablets offered by us are cardiovascular medications meticulously coated to protect the tablets from temperature and humidity constraints. These are basically prodrugs and are available in 2.5mg, 5mg concentrations. The liver esterase enzymes convert these Ramipril to the active metabolite ramiprilat, which is excreted by the kidneys and have half-life of 3-16 hours. However, its life is extended incase of heart, liver or kidney failure.

We are engaged in exporting simvastatin tablets (5mg, 10mg) that are basically an addition to diet for many patients. These cardiovascular tablets undergo several tests to achieve higher drug concentrations than humans achieve at recommended dosing. Our cardiovascular tablets bear exact concentration of the active ingredients and are effective in reducing the risk of :

• Coronary heart disease (CHD) and high cholesterol.
• Death by reducing coronary death .
  
• Heart attack.
• Undergoing cardiac procedures (coronary artery bypass grafting and percutaneous trans luminal coronary angioplasty) .
  
• Stroke or transient ischemic attack (TIA).